Progress in osteoporosis and fracture prevention: focus on postmenopausal women

por Saag, Kenneth G, Geusens, Piet
Publicado em 2009

Epidemiology, risk factors, and lifestyle modifications for gout

por Saag, Kenneth G, Choi, Hyon
Publicado em 2006

Prevention and Treatment of Bone Changes Associated with Exposure to Glucocorticoids

por Warriner, Amy, Saag, Kenneth G
Publicado em 2013

Osteoporotic fractures in older adults

por Colón-Emeric, Cathleen S., Saag, Kenneth G.
Publicado em 2006

Serum urate, menopause, and postmenopausal hormone use: from eminence to evidence-based medicine

por Gaffo, Angelo L, Saag, Kenneth G
Publicado em 2008

Febuxostat: the evidence for its use in the treatment of hyperuricemia and gout

por Gaffo, Angelo L, Saag, Kenneth G
Publicado em 2010

Anabolics in the management of glucocorticoid-induced osteoporosis: an evidence-based review of long-term safety, efficacy and place in therapy

por Taylor, Adam D, Saag, Kenneth G
Publicado no Core Evid (2019)

Healthcare Providers' Recommendations for Physical Activity among US Arthritis Population: A Cross-Sectional Analysis by Race/Ethnicity

por Austin, Shamly, Saag, Kenneth G., Pisu, Maria
Publicado no Arthritis (2018)

Long-term Safety Concerns of Antiresorptive Therapy

por Zhang, Jie, Saag, Kenneth G., Curtis, Jeffrey R.
Publicado no Rheum Dis Clin North Am (2011)

Improving drug adherence in osteoporosis: an update on more recent studies

por Jaleel, Ayesha, Saag, Kenneth G., Danila, Maria I.
Publicado no Ther Adv Musculoskelet Dis (2018)

Glucocorticoid-induced osteoporosis: from clinical trials to clinical practice

por Adami, Giovanni, Rahn, Elizabeth J, Saag, Kenneth G
Publicado no Ther Adv Musculoskelet Dis (2019)

Factors influencing the effectiveness of allopurinol in achieving and sustaining target serum urate in the national Veterans Administration gout cohort

por Singh, Jasvinder A., Yang, Shuo, Saag, Kenneth G.
Publicado no J Rheumatol (2019)

Gout. Hyperuricemia and cardiovascular disease: how strong is the evidence for a causal link?

por Gaffo, Angelo L, Edwards, N Lawrence, Saag, Kenneth G
Publicado em 2009

Should bisphosphonates be used for long-term treatment of glucocorticoid-induced osteoporosis?

por Teitelbaum, Steven L., Seton, Margaret P., Saag, Kenneth G.
Publicado em 2011

Mortality and osteoporotic fractures: is the link causal, and is it modifiable?

por Teng, Gim Gee, Curtis, effrey R., Saag, Kenneth G.
Publicado em 2008

Hypophosphatemia in the setting of metabolic bone disease: case reports and diagnostic algorithm

por Day, Alvin Lee, Morgan, Sarah L., Saag, Kenneth G.
Publicado no Ther Adv Musculoskelet Dis (2018)

Tools and Methods for Real-World Evidence Generation: Pragmatic Trials, Electronic Consent, and Data Linkages

por Curtis, Jeffrey R, Foster, P. Jeff, Saag, Kenneth G.
Publicado no Rheum Dis Clin North Am (2019)

Is there a role for cherries in the management of gout?

por Collins, Marcum W., Saag, Kenneth G., Singh, Jasvinder A.
Publicado no Ther Adv Musculoskelet Dis (2019)

Taking an Interdisciplinary Approach to Understanding and Improving Medication Adherence

por Saag, Kenneth G., Bhatia, Smita, Mugavero, Michael J., Singh, Jasvinder A.
Publicado no J Gen Intern Med (2017)

Just the FRAX: Management of Glucocorticoid-Induced Osteoporosis

por WALLACE, BETH, SAAG, KENNETH G., CURTIS, JEFFREY R., WALJEE, AKBAR K.
Publicado no Gastroenterology (2018)